Induction of an anticancer immune response is typically dependent on tumor infiltration by activated, tumor-targeting immune-effector cells such as CD8+ T lymphocytes (T cells) and natural killer (NK) cells [3]. The gene discussed is CD8A; the disease is neoplasm.